Tele: 561.316.3330

Breaking Medical Device Industry News

Tuesday, October 26, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeBioStable Science & Engineering

BioStable Science & Engineering

HAART 200 Aortic Annuloplasty Device: 1st European Commercialization Implantation Reported

First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair was performed by Professor Marek Jasinski at the Wroclaw Medical University.

BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART 300 Aortic Annuloplasty Device

June 14, 2017 BioStable Science & Engineering, Inc. announced today the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown,...

BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device

Joe Cunningham, BioStable board member and Managing Director of lead investor Santé Ventures, added, “We are very grateful for the cooperation between the BioStable management team and FDA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy